Click For Photo: https://cdn01.dailycaller.com/wp-content/uploads/2019/12/GettyImages-1192710912-e1575909358197.jpg
The Food and Drug Administration warned Monday that eliminating restrictions on abortion drugs, as 2020 presidential candidate Pete Buttigieg suggested, could cause “serious complications” for women.
The South Bend mayor suggested ignoring the FDA’s Risk Evaluation and Mitigation Strategy (REMS) applied to the abortion drug mifepristone in a Nov. 25 survey conducted by The New York Times. REMS is an FDA drug safety program the agency requires “for certain medications with serious safety concerns.”
Steps - Interim - Access - Abortion - Access
“Steps we can take in the interim to improve access to abortion include expanding access to abortion via telehealth, eliminating the Risk Evaluation and Mitigation Strategy (REMS) warning that ignores decades of evidence indicating that these medications are safe, and expanding the types of medical professionals able to prescribe them,” Buttigieg told The NYT.
He also said he would make mifepristone and misoprostol, another abortion drug, available over the counter.
FDA - Daily - Caller - News - Foundation
But the FDA told the Daily Caller News Foundation on Monday that REMS is put in...
Wake Up To Breaking News!